First metabolic profile of XLR-11, a novel synthetic cannabinoid, obtained by using human hepatocytes and high-resolution mass spectrometry

Clinical Chemistry

Volumn 59, Issue 11, 2013, Pages 1638-1648

  Wohlfarth, Ariane ^a   Pang, Shaokun ^b   Zhu, Mingshe ^c   Gandhi, Adarsh S ^a   Scheidweiler, Karl B ^a   Liu, Hua Fen ^b   Huestis, Marilyn A ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b MDS SCIEX   (Canada)

^c BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID; UNCLASSIFIED DRUG; VALERIC ACID; XLR 11;

ARTICLE; CARBOXYLATION; DEFLUORINATION; DRUG METABOLISM; DRUG STRUCTURE; DRUG TRANSFORMATION; GLUCURONIDATION; HUMAN; HYDROXYLATION; LIVER CELL CULTURE; MASS SPECTROMETRY;

CANNABINOIDS; DESIGNER DRUGS; HEPATOCYTES; HUMANS; MASS SPECTROMETRY;

EID: 84887082348     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2013.209965     Document Type: Article

References (25)

1. Frost JM, Dart MJ, Tietje KR, Garrison TR, Grayson GK, Daza AV, et al. Indol-3-ylcycloalkyl ketones: effects of N1 substituted indole side chain variations on CB(2) cannabinoid receptor activity. J Med Chem 2009;53:295-315.
2. Huffman JW. Cannabimimetic indoles, pyrroles and indenes. Curr Med Chem 1999;6:705-20. (Pubitemid 29399500)
3. Makriyannis A, Deng H. Cannabimimetic indole derivatives. Patent WO/2001/028557, 2001.
4. Sedefov R, Gallegos A, Kind L, Lopez D, Auwarter V, Hughes B. EMCDDA 2009 thematic paper - understanding the 'Spice' phenomenon. Office for Official Publications of the European Communities, 2009. www.emcdda.europa.eu/ attachements.cfm/att-80086-EN-SpiceThematicpaperfinalversion.pdf (Accessed August 2013).
5. Psychonaut Web Mapping Research Group. Spice report. Institute of Psychiatry, King's College London, 2009. www.psychonautproject.eu/documents/ reports/Spice.pdf (Accessed August 2013).
6. American Association of Poison Control Centers. Synthetic marijuana data: August 31, 2013. https://aapcc.s3.amazonaws.com/files/library/Synthetic- Marijuana-Data-for-Website-8.31.2013.pdf (Accessed September 2013).
7. Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. The DAWN report: drug-related emergency department visits involving synthetic cannabinoids, 2012. www.samhsa.gov/data/2k12/DAWN105/SR105-synthetic-marijuana.pdf (Accessed August 2013).
8. Center for Substance Abuse Research. Synthetic marijuana third most reported substance used by US high school students. CESAR FAX. 2013. www.cesar.umd.edu/cesar/cesarfax/vol22/22-17.pdf(Accessed August 2013).
9. Stogner JM, Miller BL. A spicy kind of high: A profile of synthetic cannabinoid users. J Subs Use 2013;0:1-7.
10. Chimalakonda KC, Seely KA, Bratton SM, Brents LK, Moran CL, Endres GW, et al. Cytochrome P450-mediated oxidative metabolism of abused synthetic cannabinoids found in K2/Spice: identification of novel cannabinoid receptor ligands. Drug Metab Dispos 2012;40:2174-84.
11. Grigoryev A, Kavanagh P, Melnik A. The detection of the urinary metabolites of 1-[(5-fluoropentyl)-1hindol- 3-yl]-(2-iodophenyl)methanone (AM-694), a high affinity cannabimimetic, by gas chromatographymass spectrometry. Drug Test Anal 2012;5:110-5.
12. Grigoryev A, Kavanagh P, Melnik A. The detection of the urinary metabolites of 3-[(adamantan- 1-yl)carbonyl]-1-pentylindole (AB-001), a novel cannabimimetic, by gas chromatography-mass spectrometry. Drug Test Anal 2012;4:519 -24.
13. Grigoryev A, Melnik A, Savchuk S, Simonov A, Rozhanets V. Gas and liquid chromatographymass spectrometry studies on the metabolism of the synthetic phenylacetylindole cannabimimetic JWH-250, the psychoactive component of smoking mixtures. J Chromatogr B Analyt Technol Biomed Life Sci 2011;879:2519 -26.
14. Hutter M, Broecker S, Kneisel S, Auwarter V. Identification of the major urinary metabolites in man of seven synthetic cannabinoids of the aminoalkylindole type present as adulterants in "herbal mixtures" using LC-MS/MS techniques. J Mass Spectrom 2012;47:54-65.
15. Kavanagh P, Grigoryev A, Melnik A, Simonov A. The identification of the urinary metabolites of 3-(4-methoxybenzoyl)-1-pentylindole (RCS-4), a novel cannabimimetic, by gas chromatographymass spectrometry. J Anal Toxicol 2012;36:303- 11.
16. Sobolevsky T, Prasolov I, Rodchenkov G. Detection of urinary metabolites of AM-2201 and UR- 144, two novel synthetic cannabinoids. Drug Test Anal 2012;4:745-53.
17. Department of Justice, Drug Enforcement Administration. Schedules of controlled substances: Temporary placement of three synthetic cannabinoids into schedule, Federal Register Vol. 78, 2013. http://www.gpo.gov/fdsys/pkg/FR-2013- 05-16/html/2013-11593.htm (Accessed August 2013).
18. Shevyrin V, Melkozerov V, Nevero A, Eltsov O, Morzherin Y, Shafran Y. Identification and analytical properties of new synthetic cannabimimetics bearing 2, 2, 3, 3-tetramethylcyclopropanecarbonyl moiety. Forensic Sci Int 2012;226:62-73.
19. Uchiyama N, Kawamura M, Kikura-Hanajiri R, Goda Y. URB-754: A new class of designer drug and 12 synthetic cannabinoids detected in illegal products. Forensic Sci Int 2012;227:21-32.
20. European Monitoring Centre for Drugs and Drug Abuse. European database on new drugs. https://ednd-cma.emcdda.europa.eu (Accessed May 2013).
21. NMS Labs. Designer drug trends report: changes in the designer drug market Spring 2012www.nmslabs.com/uploads/PDF/DesignerDrugSpringUpdate- BKLWebinar-May2012.pdf(Accessed August 2013).
22. Center for Disease Control and Prevention (CDC). Acute kidney injury associated with synthetic cannabinoid use. MMWR Morb Mortal Wkly Rep 2013;62:93- 8.
23. Thornton SL, Wood C, Friesen MW, Gerona RR. Synthetic cannabinoid use associated with acute kidney injury. Clin Tox 2013;51:189 -90.
24. Kavanagh P, Grigoryev A, Savchuk S, Mikhura I, Formanovsky A. UR-144 in products sold via the internet: identification of related compounds and characterization of pyrolysis products. Drug Test Anal 2013;5:63892.
25. Molinspiration Property Calculation Service. www.molinspiration.com (Accessed May 2013).